Bristol-Myers Squibb | BMY - Gross Profit On Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Bristol-Myers Squibb

Bristol-Myers Squibb reported $8.77B in Gross Profit on Sales for its fiscal quarter ending in March of 2023.


Gross Profit On Sales Change
Abbott ABT:US USD 5.42B 135M
ALKERMES ALKS:US USD 229.42M 21.29M
Amgen AMGN:US USD 4.42B 669M
AstraZeneca AZN:LN USD 8.83B 130M
Biogen BIIB:US USD 1.8B 172.9M
Bristol-Myers Squibb BMY:US USD 8.77B 114M
Catalent CTLT:US USD 387M 129M
Drreddys Laboratories RDY:US INR 36B 4.1B
Eli Lilly LLY:US USD 5.33B 420.4M
Endo International ENDP:US USD 347.82M 10.83M
Gilead Sciences GILD:US USD 4.95B 1.04B
GlaxoSmithKline GSK:LN GBP 5.05B 151M
Horizon Pharma HZNP:US USD 623.5M 77.75M
Intercept Pharmaceuticals ICPT:US USD 67.74M 9.46M
J&J JNJ:US USD 16.35B 356M
Merck & Co MRK:US USD 11.14B 1.15B
Novartis NOVN:VX USD 9.38B 215M
Perrigo PRGO:US USD 413.8M 31.2M
Pfizer PFE:US USD 13.26B 1.21B
Phibro Animal Health PAHC:US USD 75.54M 1.84M
Regeneron Pharmaceuticals REGN:US USD 2.7B 169.2M
Revance Therapeutics RVNC:US USD 33.16M 6.75M
Roche Holding ROG:VX CHF 22.04B 696M
United Therapeutics UTHR:US USD 454.6M 21.9M
Zoetis ZTS:US USD 1.45B 57M